Top

Journal of Cardiovascular Translational Research

Published in:

30-03-2022 | Myocardial Infarction | Original Article

Functional Impact and Regulation of Alternative Splicing in Mouse Heart Development and Disease

Authors: Carlos Martí-Gómez, Javier Larrasa-Alonso, Marina López-Olañeta, María Villalba-Orero, Pablo García-Pavía, Fátima Sánchez-Cabo, Enrique Lara-Pezzi

Published in: Journal of Cardiovascular Translational Research | Issue 6/2022

Abstract

Alternative splicing (AS) plays a major role in the generation of transcript diversity. In the heart, roles have been described for some AS variants, but the global impact and regulation of AS patterns are poorly understood. Here, we studied the AS profiles in heart disease, their relationship with heart development, and the regulatory mechanisms controlling AS dynamics in the mouse heart. We found that AS profiles characterized the different groups and that AS and gene expression changes affected independent genes and biological functions. Moreover, AS changes, specifically in heart disease, were associated with potential protein–protein interaction changes. While developmental transitions were mainly driven by the upregulation of MBNL1, AS changes in disease were driven by a complex regulatory network, where PTBP1 played a central role. Indeed, PTBP1 over-expression was sufficient to induce cardiac hypertrophy and diastolic dysfunction, potentially by perturbing AS patterns.

Available only for authorised users

Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., Delling, F. N., Djousse, L., Elkind, M. S. V., Ferguson, J. F., Fornage, M., Jordan, L. C., Khan, S. S., Kissela, B. M., Knutson, K. L., … Null, N. (2019). Heart disease and stroke statistics—2019 update: A report from the American Heart Association. Circulation, 139(10), e56–e66. https://doi.org/10.1161/CIR.0000000000000659CrossRef

Lareau, L. F., Green, R. E., Bhatnagar, R. S., & Brenner, S. E. (2004). The evolving roles of alternative splicing. Current Opinion in Structural Biology, 14(3), 273–282. https://doi.org/10.1016/j.sbi.2004.05.002CrossRef

Barbosa-Morais, N. L., Irimia, M., Pan, Q., Xiong, H. Y., Gueroussov, S., Lee, L. J., Slobodeniuc, V., Kutter, C., Watt, S., Çolak, R., Kim, T., Misquitta-Ali, C. M., Wilson, M. D., Kim, P. M., Odom, D. T., Frey, B. J., & Blencowe, B. J. (2012). The evolutionary landscape of alternative splicing in vertebrate species. Science, 338(6114), 1587–1593. https://doi.org/10.1126/science.1230612CrossRef

Lahmers, S., Wu, Y., Call, D. R., Labeit, S., & Granzier, H. (2004). Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium. Circulation Research, 94(4), 505–513. https://doi.org/10.1161/01.res.0000115522.52554.86CrossRef

Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., Timmers, A. M., Hauswirth, W. W., & Swanson, M. S. (2003). A muscleblind knockout model for myotonic dystrophy. Science, 302(5652), 1978–1980. https://doi.org/10.1126/science.1088583CrossRef

Kalsotra, A., & Cooper, T. A. (2011). Functional consequences of developmentally regulated alternative splicing. Nature Reviews. Genetics, 12(10), 715–729.CrossRef

Baralle, F. E., & Giudice, J. (2017). Alternative splicing as a regulator of development and tissue identity. Nature Reviews Molecular Cell Biology, 18(7), 437–451. https://doi.org/10.1038/nrm.2017.27CrossRef

Yang, Y. C., Di, C., Hu, B., Zhou, M., Liu, Y., Song, N., Li, Y., Umetsu, J., & Lu, Z. J. (2015). CLIPdb: A CLIP-seq database for protein-RNA interactions. BMC Genomics, 16(1), 51. https://doi.org/10.1186/s12864-015-1273-2CrossRef

Orchard, S., Ammari, M., Aranda, B., Breuza, L., Briganti, L., Broackes-Carter, F., Campbell, N. H., Chavali, G., Chen, C., Del-Toro, N., Duesbury, M., Dumousseau, M., Galeota, E., Hinz, U., Iannuccelli, M., Jagannathan, S., Jimenez, R., Khadake, J., Lagreid, A., … Hermjakob, H. (2014). The MIntAct project – IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Research, 42(Database issue), D358-363. https://doi.org/10.1093/nar/gkt1115CrossRef

10.

Ghadie, M. A., Lambourne, L., Vidal, M., & Xia, Y. (2017). Domain-based prediction of the human isoform interactome provides insights into the functional impact of alternative splicing. PLoS Computational Biology, 13(8), e1005717. https://doi.org/10.1371/journal.pcbi.1005717CrossRef

11.

Yang, X., Coulombe-Huntington, J., Kang, S., Sheynkman, G. M., Hao, T., Richardson, A., Sun, S., Yang, F., Shen, Y. A., Murray, R. R., Spirohn, K., Begg, B. E., Duran-Frigola, M., Macwilliams, A., Pevzner, S. J., Zhong, Q., Trigg, S. A., Tam, S., Ghamsari, L., … Vidal, M. (2016). Widespread expansion of protein interaction capabilities by alternative splicing. Cell, 164(4), 805–817. https://doi.org/10.1016/j.cell.2016.01.029CrossRef

12.

Linares, A. J., Lin, C. H., Damianov, A., Adams, K. L., Novitch, B. G., & Black, D. L. (2015). The splicing regulator PTBP1 controls the activity of the transcription factor Pbx1 during neuronal differentiation. eLife, 4e09268. https://doi.org/10.7554/eLife.09268

13.

Richards, D. A., Aronovitz, M. J., Calamaras, T. D., Tam, K., Martin, G. L., Liu, P., Bowditch, H. K., Zhang, P., Huggins, G. S., & Blanton, R. M. (2019). Distinct phenotypes induced by three degrees of transverse aortic constriction in mice. Scientific Reports, 9(1), 5844. https://doi.org/10.1038/s41598-019-42209-7CrossRef

14.

Tapial, J., Ha, K. C. H., Sterne-Weiler, T., Gohr, A., Braunschweig, U., Hermoso-Pulido, A., Quesnel-Vallières, M., Permanyer, J., Sodaei, R., Marquez, Y., Cozzuto, L., Wang, X., Gómez-Velázquez, M., Rayon, T., Manzanares, M., Ponomarenko, J., Blencowe, B. J., & Irimia, M. (2017). An atlas of alternative splicing profiles and functional associations reveals new regulatory programs and genes that simultaneously express multiple major isoforms. Genome Research, 27(10), 1759–1768. https://doi.org/10.1101/gr.220962.117CrossRef

15.

Gehman, L. T., Stoilov, P., Maguire, J., Damianov, A., Lin, C.-H., Shiue, L., Ares, M., Mody, I., & Black, D. L. (2011). The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain. Nature Genetics, 43(7), 706–711. http://www.nature.com/ng/journal/v43/n7/abs/ng.841.html#supplementary-information.CrossRef

16.

Lara-Pezzi, E., Desco, M., Gatto, A., & Gomez-Gaviro, M. V. (2016). Neurogenesis: Regulation by alternative splicing and related posttranscriptional processes. The Neuroscientist. https://doi.org/10.1177/1073858416678604CrossRef

17.

Lee, J.-A., Damianov, A., Lin, C.-H., Fontes, M., Parikshak, N. N., Anderson, E. S., Geschwin, D. H., Black, D. L., & Martin, K. C. (2016). Cytoplasmic Rbfox1 regulates the expression of synaptic and autism-related genes. Neuron, 89(1), 113–128. https://doi.org/10.1016/j.neuron.2015.11.025CrossRef

18.

Irimia, M., Weatheritt, R. J., Ellis, J. D., Parikshak, N. N., Gonatopoulos-Pournatzis, T., Babor, M., Quesnel-Vallières, M., Tapial, J., Raj, B., O’hanlon, D., Barrios-Rodiles, M., Sternberg, M. J. E., Cordes, S. P., Roth, F. P., Wrana, J. L., Geschwind, D. H., & Blencowe, B. J. (2014). A highly conserved program of neuronal microexons is misregulated in autistic brains. Cell, 159(7), 1511–1523. https://doi.org/10.1016/j.cell.2014.11.035CrossRef

19.

Climente-González, H., Porta-Pardo, E., Godzik, A., & Eyras, E. (2017). The functional impact of alternative splicing in cancer. Cell Reports, 20(9), 2215–2226. https://doi.org/10.1016/j.celrep.2017.08.012CrossRef

20.

Seyfried, J., Wang, X., Kharebava, G., & Tournier, C. (2005). A novel mitogen-activated protein kinase docking site in the N terminus of MEK5alpha organizes the components of the extracellular signal-regulated kinase 5 signaling pathway. Molecular and Cellular Biology, 25(22), 9820–9828. https://doi.org/10.1128/mcb.25.22.9820-9828.2005CrossRef

21.

Lee, J. H., Gao, C., Peng, G., Greer, C., Ren, S., Wang, Y., & Xiao, X. (2011). Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts. Circulation Research, 109(12), 1332–1341. https://doi.org/10.1161/circresaha.111.249433CrossRef

22.

Park, S. (2016). Defective Anks1a disrupts the export of receptor tyrosine kinases from the endoplasmic reticulum. BMB Reports, 49(12), 651–652. https://doi.org/10.5483/bmbrep.2016.49.12.186CrossRef

23.

Tong, J., Sydorskyy, Y., St-Germain, J. R., Taylor, P., Tsao, M. S., & Moran, M. F. (2013). Odin (ANKS1A) modulates EGF receptor recycling and stability. PLoS ONE, 8(6), e64817. https://doi.org/10.1371/journal.pone.0064817CrossRef

24.

Crone, S. A., Zhao, Y. Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K. L., Chen, J., Kahn, R., Condorelli, G., Ross, J., Jr., Chien, K. R., & Lee, K. F. (2002). ErbB2 is essential in the prevention of dilated cardiomyopathy. Nature Medicine, 8(5), 459–465. https://doi.org/10.1038/nm0502-459CrossRef

25.

D’uva, G., Aharonov, A., Lauriola, M., Kain, D., Yahalom-Ronen, Y., Carvalho, S., Weisinger, K., Bassat, E., Rajchman, D., Yifa, O., Lysenko, M., Konfino, T., Hegesh, J., Brenner, O., Neeman, M., Yarden, Y., Leor, J., Sarig, R., Harvey, R. P., & Tzahor, E. (2015). ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation. Nature Cell Biology, 17(5), 627–638. https://doi.org/10.1038/ncb3149CrossRef

26.

Dixon, D. M., Choi, J., El-Ghazali, A., Park, S. Y., Roos, K. P., Jordan, M. C., Fishbein, M. C., Comai, L., & Reddy, S. (2015). Loss of muscleblind-like 1 results in cardiac pathology and persistence of embryonic splice isoforms. Scientific Reports, 59042.https://doi.org/10.1038/srep09042

27.

Kalsotra, A., Xiao, X., Ward, A. J., Castle, J. C., Johnson, J. M., Burge, C. B., & Cooper, T. A. (2008). A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proceedings of the National Academy of Sciences of the United States of America, 105(51), 20333–20338. https://doi.org/10.1073/pnas.0809045105CrossRef

28.

Fu, X.-D., & Ares, M., Jr. (2014). Context-dependent control of alternative splicing by RNA-binding proteins. Nature Reviews. Genetics, 15(10), 689–701. https://doi.org/10.1038/nrg3778CrossRef

29.

Liu, Z., Wang, L., Welch, J. D., Ma, H., Zhou, Y., Vaseghi, H. R., Yu, S., Wall, J. B., Alimohamadi, S., Zheng, M., Yin, C., Shen, W., Prins, J. F., Liu, J., & Qian, L. (2017). Single-cell transcriptomics reconstructs fate conversion from fibroblast to cardiomyocyte. Nature, 551(7678), 100–104. https://doi.org/10.1038/nature24454CrossRef

30.

Fochi, S., Lorenzi, P., Galasso, M., Stefani, C., Trabetti, E., Zipeto, D., & Romanelli, M. G. (2020). The emerging role of the RBM20 and PTBP1 ribonucleoproteins in heart development and cardiovascular diseases. Genes, 11(4). https://doi.org/10.3390/genes11040402

31.

Kim, N., Stiegler, A. L., Cameron, T. O., Hallock, P. T., Gomez, A. M., Huang, J. H., Hubbard, S. R., Dustin, M. L., & Burden, S. J. (2008). Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell, 135(2), 334–342. https://doi.org/10.1016/j.cell.2008.10.002CrossRef

32.

Bassat, E., Mutlak, Y. E., Genzelinakh, A., Shadrin, I. Y., Baruch Umansky, K., Yifa, O., Kain, D., Rajchman, D., Leach, J., RiabovBassat, D., Udi, Y., Sarig, R., Sagi, I., Martin, J. F., Bursac, N., Cohen, S., & Tzahor, E. (2017). The extracellular matrix protein agrin promotes heart regeneration in mice. Nature, 547(7662), 179–184. https://doi.org/10.1038/nature22978CrossRef

33.

Hilgenberg, L. G. W., Pham, B., Ortega, M., Walid, S., Kemmerly, T., O’dowd, D. K., & Smith, M. A. (2009). Agrin regulation of alpha3 sodium-potassium ATPase activity modulates cardiac myocyte contraction. The Journal of Biological Chemistry, 284(25), 16956–16965. https://doi.org/10.1074/jbc.M806855200CrossRef

34.

Johnson, E. B., Steffen, D. J., Lynch, K. W., & Herz, J. (2006). Defective splicing of Megf7/Lrp4, a regulator of distal limb development, in autosomal recessive mulefoot disease. Genomics, 88(5), 600–609. https://doi.org/10.1016/j.ygeno.2006.08.005CrossRef

35.

Li, Y., Pawlik, B., Elcioglu, N., Aglan, M., Kayserili, H., Yigit, G., Percin, F., Goodman, F., Nürnberg, G., Cenani, A., Urquhart, J., Chung, B. D., Ismail, S., Amr, K., Aslanger, A. D., Becker, C., Netzer, C., Scambler, P., Eyaid, W., … Wollnik, B. (2010). LRP4 mutations alter Wnt/beta-catenin signaling and cause limb and kidney malformations in Cenani-Lenz syndrome. American Journal of Human Genetics, 86(5), 696–706. https://doi.org/10.1016/j.ajhg.2010.03.004CrossRef

36.

Simon-Chazottes, D., Tutois, S., Kuehn, M., Evans, M., Bourgade, F., Cook, S., Davisson, M. T., & Guénet, J. L. (2006). Mutations in the gene encoding the low-density lipoprotein receptor LRP4 cause abnormal limb development in the mouse. Genomics, 87(5), 673–677. https://doi.org/10.1016/j.ygeno.2006.01.007CrossRef

37.

Fred, R. G., Tillmar, L., & Welsh, N. (2006). The role of PTB in insulin mRNA stability control. Current Diabetes Reviews, 2(3), 363–366. https://doi.org/10.2174/157339906777950570CrossRef

38.

Li, Y. I., Sanchez-Pulido, L., Haerty, W., & Ponting, C. P. (2015). RBFOX and PTBP1 proteins regulate the alternative splicing of micro-exons in human brain transcripts. Genome Research, 25(1), 1–13. https://doi.org/10.1101/gr.181990.114CrossRef

39.

Weyn-Vanhentenryck, S. M., Feng, H., Ustianenko, D., Duffié, R., Yan, Q., Jacko, M., Martinez, J. C., Goodwin, M., Zhang, X., Hengst, U., Lomvardas, S., Swanson, M. S., & Zhang, C. (2018). Precise temporal regulation of alternative splicing during neural development. Nature Communications, 9(1), 2189. https://doi.org/10.1038/s41467-018-04559-0CrossRef

40.

Giudice, J., Xia, Z., Wang, E. T., Scavuzzo, M. A., Ward, A. J., Kalsotra, A., Wang, W., Wehrens, X. H., Burge, C. B., Li, W., & Cooper, T. A. (2014). Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development. Nature Communications, 53603.https://doi.org/10.1038/ncomms4603

41.

Dominguez, D., Freese, P., Alexis, M. S., Su, A., Hochman, M., Palden, T., Bazile, C., Lambert, N. J., Van Nostrand, E. L., Pratt, G. A., Yeo, G. W., Graveley, B. R., & Burge, C. B. (2018). Sequence, structure, and context preferences of human RNA binding proteins. Molecular Cell, 70(5), 854-867.e859. https://doi.org/10.1016/j.molcel.2018.05.001CrossRef

42.

Ray, D., Kazan, H., Cook, K. B., Weirauch, M. T., Najafabadi, H. S., Li, X., Gueroussov, S., Albu, M., Zheng, H., Yang, A., Na, H., Irimia, M., Matzat, L. H., Dale, R. K., Smith, S. A., Yarosh, C. A., Kelly, S. M., Nabet, B., Mecenas, D., … Hughes, T. R. (2013). A compendium of RNA-binding motifs for decoding gene regulation. Nature, 499(7457), 172–177. https://doi.org/10.1038/nature12311CrossRef

43.

Cherny, D., Gooding, C., Eperon, G. E., Coelho, M. B., Bagshaw, C. R., Smith, C. W., & Eperon, I. C. (2010). Stoichiometry of a regulatory splicing complex revealed by single-molecule analyses. The EMBO Journal, 29(13), 2161–2172. https://doi.org/10.1038/emboj.2010.103CrossRef

44.

Gooding, C., Edge, C., Lorenz, M., Coelho, M. B., Winters, M., Kaminski, C. F., Cherny, D., Eperon, I. C., & Smith, C. W. (2013). MBNL1 and PTB cooperate to repress splicing of Tpm1 exon 3. Nucleic Acids Research, 41(9), 4765–4782. https://doi.org/10.1093/nar/gkt168CrossRef

45.

Merkin, J., Russell, C., Chen, P., & Burge, C. B. (2012). Evolutionary dynamics of gene and isoform regulation in mammalian tissues. Science, 338(6114), 1593–1599. https://doi.org/10.1126/science.1228186CrossRef

46.

Mazin, P. V., Khaitovich, P., Cardoso-Moreira, M., & Kaessmann, H. (2021). Alternative splicing during mammalian organ development. Nature Genetics, 53(6), 925–934. https://doi.org/10.1038/s41588-021-00851-wCrossRef

Title: Functional Impact and Regulation of Alternative Splicing in Mouse Heart Development and Disease
Authors: Carlos Martí-Gómez
Javier Larrasa-Alonso
Marina López-Olañeta
María Villalba-Orero
Pablo García-Pavía
Fátima Sánchez-Cabo
Enrique Lara-Pezzi
Publication date: 30-03-2022
Publisher: Springer US
Keyword: Myocardial Infarction
Published in: Journal of Cardiovascular Translational Research / Issue 6/2022
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-022-10244-x

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Functional Impact and Regulation of Alternative Splicing in Mouse Heart Development and Disease

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2022

Correction to: The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization

Dickkopf1 (Dkk1) Alleviates Vascular Calcification by Regulating the Degradation of Phospholipase D1 (PLD1)

Investigation into the Health Effects of Reduced Chymase Function Using Predicted Loss-of-Function Mutations in CMA1

Impact of Myocardial Fibrosis on Cardiovascular Structure, Function and Functional Status in Heart Failure with Preserved Ejection Fraction

Calcitriol Supplementation Protects Against Apoptosis and Alleviates the Severity of Abdominal Aortic Aneurysm Induced by Angiotensin II and Anti-TGFβ

Chaetocin attenuates atherosclerosis progression and inhibits vascular smooth muscle cell phenotype switching

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page